Germany· DE-A57-9cfdcbd1c6a715ad
Cefixim Al
A cefixime product containing cefixime, registered in Germany by Aliud Pharma Gmbh. The same ATC class is registered in 13 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Cefixime is registered in 13 of 19 countries.
Countries holding a registration under ATC J01DD08 (cefixime), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 7 of them publish a price we can compare per daily dose
Cefixime · ATC J01DD08
13 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Ireland
- Italyprice
- Japan
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefixime costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $1.31 in Spain to $2.20 in Italy — a ×1.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cefixime · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- IT Italy$2.20
- ES Spain$1.31
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Cefixime
- Manufacturer
- Aliud Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- J01DD08
- ATC class
- Cefixime
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
21 interactions on record for cefixime.
Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefixime · interactions on record
21 records
- 20 moderate
- 1 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefixime in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyCEFIXIMA AUROBINDOAUROBINDO PHARMA ITALIA S.R.L.
- United StatesCefiximeREMEDYREPACK INC.
- SpainAFIXORA 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGCodal-Synto Limited
- FranceCEFIXIME ALMUS 200 mg, comprimé pelliculéBIOGARAN
- CzechiaCEFIXIME INNFARMINN-FARM d.o.o., Ljubljana
- United KingdomCefixime 200mg tabletsImported
- CanadaAURO-CEFIXIMEAURO PHARMA INC
- NorwayCefixim alAliud Pharma
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Cefixim Nectar, Sorcelif
- Bulgaria · Cefixime Neclife, Cefixime Viatris
- Cyprus · Cefimed, Cefixime Viatris
- Czechia · Cefixime Innfarm, Sorcelif
- Spain · Afixora, Cefixima Neclife
- France · Cefixime Almus, Cefixime Arrow
- United Kingdom (Northern Ireland) · Suprax
- Greece · Ceftoral
- Croatia · Cefiksim Alkaloid, Cefiksim Nectar
- Hungary · Cefixim Nectar, Cefixime Reiwa Healthcare
- Ireland · Cefixime Nectar Lifesciences, Suprax
- Italy · Cefixima Aurobindo, Cefixima Doc Generici
- Lithuania · Cefixime Medochemie
- Malta · Tricef
- Norway · Cefixime Frostpharma, Cefixime Medochemie
- Poland · Cetix, Xifia
- Portugal · Cefiton, Cefixim Nectar
- Romania · Axtrifia, Cefiximă Medochemie
- Sweden · Cefixime Frostpharma, Cefixime Medochemie
- Slovenia · Pancef
- Slovakia · Cefimed, Cefixim
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/48882a30-14a6-4d1c-9ae3-7d76f0ec0fee GET /v1/drugs/48882a30-14a6-4d1c-9ae3-7d76f0ec0fee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Cefixime",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about cefixime.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.